Prescription Stimulants: Balancing Access, Preventing Diversion, and Protecting Public Health and Safety

Session Description: Prescription stimulant medications are essential for treating ADHD and other legitimate medical conditions, but increasing concerns about diversion, fraudulent prescribing, misuse, and criminal exploitation present complex challenges. Addressing these issues requires protecting patient access while reducing opportunities for diversion. This session examines the evolving prescription stimulant landscape through a federal policy and public health lens. Participants will explore prescribing and diversion trends, the role of telemedicine, and current federal efforts to support responsible prescribing while addressing unlawful activity. Using current data, regulatory developments, and real-world case examples, the presentation highlights how healthcare providers, regulators, public health agencies, and law enforcement contribute to a coordinated response. Attendees will leave with practical insights into emerging risks, responsible prescribing, and the federal framework for preserving legitimate access while preventing diversion.